Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
60.13
+1.97 (3.39%)
Nov 4, 2024, 4:00 PM EST - Market closed

Korro Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21
Market Capitalization
559383--
Enterprise Value
410578--
Last Close Price
60.1347.93--
PE Ratio
--0.90--
PB Ratio
2.822.26--
P/FCF Ratio
-3.79-5.10--
P/OCF Ratio
-4.53-5.70--
EV/EBITDA Ratio
-2.39-7.14--
EV/EBIT Ratio
-2.31-6.83--
EV/FCF Ratio
-2.55-7.69--
Debt / Equity Ratio
0.190.200.05-
Debt / FCF Ratio
-0.46-0.44-0.05-
Quick Ratio
12.778.536.3523.95
Current Ratio
13.288.876.5624.20
Return on Equity (ROE)
-62.72%-69.16%-62.24%-
Return on Assets (ROA)
-31.91%-35.77%-36.63%-
Return on Capital (ROIC)
-33.74%-38.98%-38.89%-
Earnings Yield
-15.26%-21.18%--
FCF Yield
-14.81%-19.60%--
Buyback Yield / Dilution
0.02%-499.32%94.26%-
Total Shareholder Return
0.02%-499.32%94.26%-
Source: S&P Capital IQ. Standard template. Financial Sources.